FBXO32
From Wikipedia, the free encyclopedia
| F-box protein 32 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Identifiers | |||||||||||||
| Symbols | FBXO32; Fbx32; MAFbx | ||||||||||||
| External IDs | OMIM: 606604 MGI: 1914981 HomoloGene: 12182 GeneCards: FBXO32 Gene | ||||||||||||
| |||||||||||||
| Orthologs | |||||||||||||
| Species | Human | Mouse | |||||||||||
| Entrez | 114907 | 67731 | |||||||||||
| Ensembl | ENSG00000156804 | ENSMUSG00000022358 | |||||||||||
| UniProt | Q969P5 | Q9CPU7 | |||||||||||
| RefSeq (mRNA) | NM_001242463 | NM_026346 | |||||||||||
| RefSeq (protein) | NP_001229392 | NP_080622 | |||||||||||
| Location (UCSC) | Chr 8: 124.51 – 124.55 Mb | Chr 15: 58.18 – 58.21 Mb | |||||||||||
| PubMed search | |||||||||||||
F-box only protein 32 is a protein that in humans is encoded by the FBXO32 gene.[1][2][3]
This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of the ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene belongs to the Fbxs class and contains an F-box domain. This protein is highly expressed during muscle atrophy, whereas mice deficient in this gene were found to be resistant to atrophy. This protein is thus a potential drug target for the treatment of muscle atrophy. Alternative splicing of this gene results in two transcript variants encoding two isoforms of different sizes.[3]
Interactions
FBXO32 has been shown to interact with EIF3A.[4]
References
- ↑ Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, Poueymirou WT, Panaro FJ, Na E, Dharmarajan K, Pan ZQ, Valenzuela DM, DeChiara TM, Stitt TN, Yancopoulos GD, Glass DJ (Nov 2001). "Identification of ubiquitin ligases required for skeletal muscle atrophy". Science 294 (5547): 1704–8. doi:10.1126/science.1065874. PMID 11679633.
- ↑ Gomes MD, Lecker SH, Jagoe RT, Navon A, Goldberg AL (Dec 2001). "Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy". Proc Natl Acad Sci U S A 98 (25): 14440–5. doi:10.1073/pnas.251541198. PMC 64700. PMID 11717410.
- ↑ 3.0 3.1 "Entrez Gene: FBXO32 F-box protein 32".
- ↑ Lagirand-Cantaloube, Julie; Offner Nicolas, Csibi Alfredo, Leibovitch Marie P, Batonnet-Pichon Sabrina, Tintignac Lionel A, Segura Carlos T, Leibovitch Serge A (Apr 2008). "The initiation factor eIF3-f is a major target for atrogin1/MAFbx function in skeletal muscle atrophy". EMBO J. (England) 27 (8): 1266–76. doi:10.1038/emboj.2008.52. PMC 2367397. PMID 18354498.
Further reading
- Hanai J, Cao P, Tanksale P, et al. (2008). "The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity.". J. Clin. Invest. 117 (12): 3940–51. doi:10.1172/JCI32741. PMC 2066198. PMID 17992259.
- de Palma L, Marinelli M, Pavan M, Orazi A (2008). "Ubiquitin ligases MuRF1 and MAFbx in human skeletal muscle atrophy.". Joint Bone Spine 75 (1): 53–7. doi:10.1016/j.jbspin.2007.04.019. PMID 17977773.
- Mascher H, Tannerstedt J, Brink-Elfegoun T, et al. (2008). "Repeated resistance exercise training induces different changes in mRNA expression of MAFbx and MuRF-1 in human skeletal muscle.". Am. J. Physiol. Endocrinol. Metab. 294 (1): E43–51. doi:10.1152/ajpendo.00504.2007. PMID 17971512.
- de Boer MD, Selby A, Atherton P, et al. (2008). "The temporal responses of protein synthesis, gene expression and cell signalling in human quadriceps muscle and patellar tendon to disuse.". J. Physiol. (Lond.) 585 (Pt 1): 241–51. doi:10.1113/jphysiol.2007.142828. PMC 2375459. PMID 17901116.
- Petersen AM, Magkos F, Atherton P, et al. (2007). "Smoking impairs muscle protein synthesis and increases the expression of myostatin and MAFbx in muscle.". Am. J. Physiol. Endocrinol. Metab. 293 (3): E843–8. doi:10.1152/ajpendo.00301.2007. PMID 17609255.
- Kostek MC, Chen YW, Cuthbertson DJ, et al. (2007). "Gene expression responses over 24 h to lengthening and shortening contractions in human muscle: major changes in CSRP3, MUSTN1, SIX1, and FBXO32.". Physiol. Genomics 31 (1): 42–52. doi:10.1152/physiolgenomics.00151.2006. PMID 17519359.
- Doucet M, Russell AP, Léger B, et al. (2007). "Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease.". Am. J. Respir. Crit. Care Med. 176 (3): 261–9. doi:10.1164/rccm.200605-704OC. PMID 17478621.
- Ogawa T, Furochi H, Mameoka M, et al. (2006). "Ubiquitin ligase gene expression in healthy volunteers with 20-day bedrest.". Muscle Nerve 34 (4): 463–9. doi:10.1002/mus.20611. PMID 16868939.
- Léger B, Vergani L, Sorarù G, et al. (2006). "Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1.". FASEB J. 20 (3): 583–5. doi:10.1096/fj.05-5249fje. PMID 16507768.
- Rual JF, Venkatesan K, Hao T, et al. (2005). "Towards a proteome-scale map of the human protein-protein interaction network.". Nature 437 (7062): 1173–8. doi:10.1038/nature04209. PMID 16189514.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs.". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.